Large-scale study finds genetic variant responsible for detrimental immune response to common anti-inflammatory drugs
Researchers in the UK seek to understand why commonly used medication fails to treat Chron's disease by identifying a new genetic marker. The research published in Gastroenterology on October 7, identified a genetic variation that decreases the efficiency of anti-tumor necrosis factor (anti-TNF) drugs.
Success of immunotherapies increased in cancer patients through co-treatment with monoclonal antibodies
A new approach provides evidence that it is possible to break down the protective wall surrounding tumor cells, therefore making immunotherapies more effective in patients with a variety of cancers. This research, funded by Cancer Research UK, was published in the EBioMedicine on August 25th. Discuss
New immunotherapy moves further into clinical testing with promising results
Success in international clinical trials leads to U.S. based research organizations beginning phase I/II clinical trials. If this form of immunotherapy is successful and deemed safe, then it could save the lives of liver cancer patients across the world. Discuss
Conferences
Society for Laboratory Automation and Screening (SLAS) 2020
January 25-29
San Diego, California United States
January 25-29
San Diego, California United States
American Society for Microbiology (ASM) Biothreats
January 28-30
Arlington, Virginia United States
January 28-30
Arlington, Virginia United States
Festival of Genomics 2020
January 29-30
London, Greater London United Kingdom
January 29-30
London, Greater London United Kingdom
Medlab Middle East
February 3-6
Dubai, Dubai United Arab Emirates
February 3-6
Dubai, Dubai United Arab Emirates
Japan Analytical & Scientific Instruments Show (JASIS)
November 11-13
Chiba, Chiba Japan
November 11-13
Chiba, Chiba Japan
|
General Discussion
|
||
| Topic | Replies / Views | Last Update |
|---|---|---|
|
Open science for the modern scientific community
|
1 / 19 | More than 3 days ago |
|
PopSci Hails Impossible Burger 2.0 as Most Important Engineering Innovation in 2019
|
0 / 5 | More than 3 days ago |
|
Engineered Bacteria Produces BeeFree Honey
|
0 / 3 | More than 3 days ago |
|
Consumers' Preference to Buy Unlabeled Produce Increases after Exposure to GMO-labeled Pro
|
0 / 13 | More than 3 days ago |
|
Super-precise new CRISPR tool could tackle a plethora of genetic diseases
|
0 / 13 | More than 3 days ago |
| To see more posts from our community or to share a post of your own, go to our community's forum page. | ||
Insights
Exclusive content for Science Advisory Board members on trends and outcomes that are influencing the future of scientific research.
Communities
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Rewards
Earn points for contributing to research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Connect
